Added value of H-FABP as a plasma biomarker for the early evaluation of suspected acute coronary syndrome

Jan F. C. Glatz*, Reinhard Renneberg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Web of Science)
Original languageEnglish
Pages (from-to)205-220
JournalClinical Lipidology
Issue number2
Publication statusPublished - Apr 2014


  • acute coronary syndrome
  • acute myocardial infarction
  • early diagnosis
  • FABP3
  • fatty acid-binding protein
  • H-FABP
  • plasma biomarker
  • point-of-care test

Cite this